#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pleural mesothelioma Pulmonary tuberculosis Fungal infection Liver abscess Thromboangiitis obliterans Cutaneous calcification Antiphospholipid syndrome Gastrointestinal disorder B-cell lymphoma recurrent Essential thrombocythaemia Primary biliary cholangitis Prophylaxis against transplant rejection Fibrosarcoma Thrombocytopenia Dermatomyositis More trials…

    Learn about Rare Diseases

    Proteus syndrome – Basic Information Castleman’s disease – Treatment Basal cell naevus syndrome – Diagnostics Alternating hemiplegia of childhood – Basic Information Turner’s syndrome – Basic Information Rhabdoid tumour – Trials in Disease Osteosarcoma Paroxysmal nocturnal haemoglobinuria – Diagnostics Primary biliary cholangitis – Life with Disease Haemophilia A without inhibitors – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bempedoic Acid VG801-1 Icosapent Ethyl Menotrophin Capmatinib Teprenone Regorafenib Desflurane Gs-4182 Selexipag LY3372993 Temocillin Fexofenadine Izaflortaucipir (18F) Azd8630 Sotalol Hydrochloride Potassium Canrenoate Calcium Polystyrene Sulfonate Placebo Minocycline Hydrochloride More therapies…

    Learn about Your Condition

    Mitral valve disease Pancreatic carcinoma recurrent Craniosynostosis Post-acute COVID-19 syndrome Ventricular fibrillation Angiosarcoma metastatic Primary hypercholesterolaemia Colonoscopy Type IIa hyperlipidaemia Anxiety Small intestine leiomyosarcoma Follicular lymphoma stage IV Pulmonary sarcoidosis Leiomyosarcoma Rectal cancer stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study on the Effectiveness and Safety of Osimertinib for Patients with Stage IB-IIIA Non-Small Cell Lung Cancer After Tumor Removal

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage I
    • Non-small cell lung cancer stage II
    • Non-small cell lung cancer stage III
    Investigated Drugs:
    • Osimertinib
    Belgium France Germany Italy Poland Spain +1

  • Study on the Long-term Effects of Givinostat for Patients with JAK2V617F Positive Chronic Myeloproliferative Neoplasms

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Givinostat
    Italy

  • Study on Health, Activity, and Joint Outcomes in Patients Aged 13-69 with Severe or Moderate Hemophilia A Using Emicizumab

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Emicizumab
    Germany Hungary Italy Spain

  • Study on the Effectiveness and Safety of Crovalimab vs. Eculizumab for Adults and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Treated with Complement Inhibitors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Paroxysmal nocturnal haemoglobinuria
    Investigated Drugs:
    • Crovalimab
    • Eculizumab
    France Germany Lithuania The Netherlands Poland Portugal +3

  • Study on the Effectiveness of Decitabine and Tetrahydrouridine in Patients with Sickle Cell Disease Not Eligible for Hydroxyurea Treatment

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Sickle cell disease
    Investigated Drugs:
    • Decitabine
    • Tetrahydrouridine
    • Hydroxycarbamide
    France Greece Italy Spain

  • Study on the Effectiveness and Safety of Iptacopan for Adults with Atypical Hemolytic Uremic Syndrome Not Previously Treated with Complement Inhibitors

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Atypical haemolytic uraemic syndrome
    Investigated Drugs:
    • Iptacopan
    Austria Czechia Greece Slovakia Slovenia
Previous Page
1 … 72 73 74 75 76 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!